Up to 10% of #cancers are thought to be caused by #genetic changes that are passed from parent to child. The FDA has granted marketing authorization for [the Invitae Common Hereditary #Cancers Panel] blood test that detects inherited #genetic changes that may increase the risk of developing certain #cancers. The test is the first of its kind to be granted marketing authorization. "This particular [#germline #genetic] test is the first to have undergone FDA's critical review to demonstrate that it is safe and effective for its intended use"- #DrLoriMinasian @ NCI Division of Cancer Prevention, National Cancer Institute (NCI) #patient #access #reducedisparities #germlinetesting #genetictesting #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention https://lnkd.in/gb2ChzrP
Founder, CEO @ Genome Creative | Educating People About Precision Medicine
10moSign me up!